SCHEMBL5318950

SCHEMBL5318950

Nc1ccc2c(/C=C/C(=O)O)nn(Cc3ccc(F)cc3F)c2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 2/20 0.43
PTGDR2 Q9Y5Y4 4/20 0.39
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C8 P10632 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2A6 P11509 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2B6 P20813 1/20 0.38
CYP2C19 P33261 1/20 0.38
PTGDR Q13258 1/20 0.38
AKR1B1 P15121 1/20 0.37
GUCY1A1 Q02108 4/20 0.37
GUCY1B1 Q02153 4/20 0.37
SLC22A12 Q96S37 1/20 0.37
PTGER1 P34995 1/20 0.36
PPARG P37231 1/20 0.36
TDO2 P48775 1/20 0.36
PKM P14618 1/20 0.35
ESR1 P03372 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5318952 1.00 ENPP2 (0.43) ENPP2PTGDR2CYP1A2CYP3A4CYP2C8
SCHEMBL1049586 0.92 ENPP2 (0.46) ENPP2PTGDR2CYP1A2CYP3A4CYP2C8
SCHEMBL1049585 0.92 ENPP2 (0.46) ENPP2PTGDR2CYP1A2CYP3A4CYP2C8
SCHEMBL5321447 0.90 ENPP2 (0.48) ENPP2CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL5269926 0.90 ENPP2 (0.46) ENPP2CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL5321449 0.90 ENPP2 (0.48) ENPP2CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL5321725 0.88 ENPP2 (0.38) ENPP2PTGDR2CYP1A2CYP3A4CYP2C8
SCHEMBL5321729 0.88 ENPP2 (0.38) ENPP2PTGDR2CYP1A2CYP3A4CYP2C8
SCHEMBL1050476 0.88 ENPP2 (0.52) ENPP2PTGDR2CYP1A2CYP3A4CYP2C8
SCHEMBL1047075 0.88 PTGDR2 (0.43) ENPP2PTGDR2CYP1A2CYP3A4CYP2C8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1786424-A2 LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT The University of Kansas (US) 2007-05-23 EP claimed
WO-2006023704-A2 LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT UNIVERSITY OF KANSAS (US) 2006-03-02 WO claimed